Patent · US Active

Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors

US8338604B2 · kind B2 · utility

2Cited by

9References

8Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

John Hynes · Washington Crossing, US
George V. De Lucca · Wilmington, US
Hong Wu · Meekrap-oord, CN

Key dates

Filing date	Jun 18, 2009
Grant date	Dec 25, 2012
Priority date	—
Expiry date	Jun 18, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of Formula (I) or Formula (II) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) or Formula (II), and methods of treating conditions associated with the activity of p38 kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.